Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3FX4

Porcine aldehyde reductase in ternary complex with inhibitor

Summary for 3FX4
Entry DOI10.2210/pdb3fx4/pdb
Related2AO0 3CV7
DescriptorAlcohol dehydrogenase [NADP+], SULFATE ION, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... (5 entities in total)
Functional Keywordstim barrel, aldo-keto reductase, ternary complex, acetylation, nadp, oxidoreductase
Biological sourceSus scrofa (Pig)
Total number of polymer chains1
Total formula weight38025.88
Authors
Carbone, V.,El-Kabbani, O. (deposition date: 2009-01-20, release date: 2009-12-22, Last modification date: 2023-11-01)
Primary citationCarbone, V.,Giglio, M.,Chung, R.,Huyton, T.,Adams, J.,Maccari, R.,Ottana, R.,Hara, A.,El-Kabbani, O.
Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
Eur.J.Med.Chem., 45:1140-1145, 2010
Cited by
PubMed Abstract: The structure of aldehyde reductase (ALR1) in ternary complex with the coenzyme NADPH and [5-(3-carboxymethoxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid (CMD), a potent inhibitor of aldose reductase (ALR2), was determined at 1.99A resolution. The partially disordered inhibitor formed a tight network of hydrogen bonds with the active site residues (Tyr50 and His113) and coenzyme. Molecular modelling calculations and inhibitory activity measurements of CMD and [5-(3-hydroxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid (HMD) indicated that pi-stacking interactions with several conserved active site tryptophan residues and hydrogen-bonding interactions with the non-conserved C-terminal residue Leu300 in ALR2 (Pro301 in ALR1) contributed to inhibitor selectivity. In particular for the potent inhibitor CMD, the rotameric state of the conserved residue Trp219 (Trp220 in ALR1) is important in forming a pi-stacking interaction with the inhibitor in ALR2 and contributes to the difference in the binding of the inhibitor to the enzymes.
PubMed: 20036445
DOI: 10.1016/j.ejmech.2009.12.019
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.99 Å)
Structure validation

245011

数据于2025-11-19公开中

PDB statisticsPDBj update infoContact PDBjnumon